Namwiwat Medical Corporation PCL (BKK:NAM)
Thailand · Delayed Price · Currency is THB 3.300
+0.020 (0.61%)
Last updated: Sep 8, 2026, 2:17 PM ICT
BKK:NAM Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,282 | 2,450 | 3,220 | 4,865 | - | - | |
Market Cap Growth | -21.63% | -23.91% | -33.81% | - | - | - |
Enterprise Value | 2,164 | 2,339 | 2,473 | 4,877 | - | - |
Last Close Price | 3.26 | 3.47 | 4.28 | 6.36 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.06 | 24.12 | 17.80 | 24.23 | - | - |
Forward PE | - | 13.76 | 13.76 | 17.38 | - | - |
PS Ratio | 1.35 | 1.31 | 2.89 | 4.42 | - | - |
PB Ratio | 1.08 | 1.17 | 1.54 | 2.48 | - | - |
P/TBV Ratio | 1.19 | 1.28 | 1.59 | 2.51 | - | - |
P/FCF Ratio | 60.46 | - | - | 21.31 | - | - |
P/OCF Ratio | 31.34 | 64.71 | 140.39 | 18.81 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.28 | 1.25 | 2.22 | 4.43 | - | - |
EV/EBITDA Ratio | 12.58 | 11.02 | 10.38 | 17.73 | - | - |
EV/EBIT Ratio | 20.12 | 15.00 | 11.65 | 19.51 | - | - |
EV/FCF Ratio | 57.32 | - | - | 21.36 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.22 | 0.24 | 0.17 | 0.12 | 0.22 | 0.88 |
Debt / EBITDA Ratio | 2.74 | 2.26 | 1.44 | 0.83 | 1.08 | 1.54 |
Debt / FCF Ratio | 12.51 | - | - | 1.01 | - | 4.01 |
Net Debt / Equity Ratio | -0.10 | -0.10 | -0.30 | -0.44 | -0.08 | 0.78 |
Net Debt / EBITDA Ratio | -1.31 | -0.96 | -2.65 | -3.15 | -0.40 | 1.39 |
Net Debt / FCF Ratio | -5.72 | 41.23 | 19.33 | -3.80 | 1.19 | 3.57 |
Asset Turnover | 0.57 | 0.65 | 0.44 | 0.54 | 0.80 | 1.06 |
Inventory Turnover | 1.49 | 2.01 | 1.51 | 1.64 | 2.00 | 2.26 |
Quick Ratio | 2.07 | 1.81 | 3.11 | 5.63 | 2.43 | 0.61 |
Current Ratio | 3.37 | 2.94 | 4.10 | 7.09 | 3.57 | 1.47 |
Return on Equity (ROE) | 4.04% | 5.79% | 9.01% | 12.65% | 21.45% | 49.48% |
Return on Assets (ROA) | 2.29% | 3.38% | 5.25% | 7.72% | 10.20% | 15.05% |
Return on Invested Capital (ROIC) | 4.46% | 7.54% | 13.08% | 18.14% | 18.92% | 25.64% |
Return on Capital Employed (ROCE) | 4.70% | 6.80% | 9.60% | 12.00% | 16.60% | 37.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.56% | 4.15% | 5.62% | 4.13% | - | - |
FCF Yield | 1.65% | -0.20% | -1.01% | 4.69% | - | - |
Dividend Yield | 3.94% | 3.74% | 3.50% | 1.42% | - | - |
Payout Ratio | 136.33% | 172.26% | 34.83% | 115.59% | 138.01% | - |
Buyback Yield / Dilution | - | - | -13.90% | -2237.63% | -31.45% | - |
Total Shareholder Return | 3.94% | 3.74% | -10.40% | -2236.21% | -31.45% | - |